Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 47 | 0 | 5 | 0 | €681.50 | €755.83 | 10.907% |
| Boston Scientific | 37 | 0 | 4 | 0 | €63.50 | €61.53 | -3.109% |
| Vertex Pharmaceuticals Inc. | 39 | 2 | 4 | 0 | €370.20 | €382.71 | 3.378% |
| Intuitive Surgical Inc | 35 | 0 | 3 | 0 | €343.70 | €368.20 | 7.128% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €470.35 | €543.72 | 15.599% |
| Regeneron Pharmaceuticals Inc. | 31 | 1 | 5 | 1 | €841.20 | €954.29 | 13.444% |
| Merck & Co. Inc. | 27 | 1 | 4 | 0 | €118.20 | €124.92 | 5.681% |
| Trinity Biotech ADR | 24 | 0 | 3 | 0 | €0.41 | - | - |
| Thermo Fisher Scientific Inc. | 24 | 0 | 3 | 0 | €511.40 | €561.51 | 9.798% |
| Edwards Lifesciences Corp. | 24 | 1 | 4 | 0 | €80.64 | €87.81 | 8.887% |
| Amgen Inc. | 23 | 0 | 3 | 0 | €252.45 | €293.65 | 16.319% |
| Tenet Healthcare | 23 | 0 | 3 | 0 | €87.50 | €95.79 | 9.479% |
| Cytokinetics Inc. | 24 | 1 | 4 | 0 | €63.50 | €88.82 | 39.879% |
| Neurocrine Bioscience | 21 | 0 | 3 | 0 | €123.90 | €137.10 | 10.654% |
| Intra-Cellular Therapies Inc. | 21 | 0 | 5 | 0 | €68.00 | €77.61 | 14.137% |
| Humana Inc. | 20 | 0 | 3 | 0 | €308.10 | €473.29 | 53.614% |
| R1 RCM Inc. | 19 | 0 | 3 | 0 | €11.20 | €17.21 | 53.684% |
| HCA Holdings Inc. | 19 | 0 | 2 | 0 | €286.50 | €289.08 | 0.899% |
| Natural Alternat. | 19 | 1 | 2 | 0 | €6.00 | - | - |
| BioMarin Pharmaceutical Inc. | 18 | 0 | 0 | 0 | €84.64 | €102.48 | 21.073% |
| Sutro Biopharma Inc | 18 | 0 | 7 | 0 | €3.50 | €11.05 | 215.669% |
| Dexcom Inc. | 17 | 0 | 2 | 0 | €122.72 | €136.81 | 11.482% |
| Stryker Corp. | 17 | 0 | 4 | 0 | €305.40 | €331.52 | 8.554% |
| AbbVie Inc. | 18 | 1 | 3 | 1 | €156.20 | €175.79 | 12.540% |
| Pro-Dex Inc. | 17 | 0 | 0 | 0 | €16.50 | - | - |